Legal Representation
Attorney
Scott Rogers
USPTO Deadlines
Next Deadline
1446 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-27)
Due Date
June 27, 2029
Grace Period Ends
December 27, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
28 eventsDate | Code | Type | Description |
---|---|---|---|
Oct 16, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Sep 27, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Sep 27, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED |
Sep 27, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Jun 27, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jun 27, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Jun 11, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
May 24, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
May 24, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Apr 13, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Apr 11, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 11, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Mar 22, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 22, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Mar 22, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Mar 9, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 7, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Mar 7, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 7, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 18, 2022 | RFNT | P | REFUSAL PROCESSED BY IB |
Sep 29, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU |
Sep 29, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Aug 9, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Aug 8, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Aug 2, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Jan 4, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Dec 29, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Dec 23, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Chemical preparations for medical, pharmaceutical or veterinary use, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceutical preparations, namely, for leaky gut, pulmonary diseases, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, inflammatory lung diseases, and gastrointestinal diseases; pharmaceuticals, namely, gut microbiome stabilizators and quorum sensing inhibitors
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMA"